Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
McKinsey
Mallinckrodt
AstraZeneca
Baxter

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Organon Usa Inc Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ORGANON USA INC, and what generic alternatives to ORGANON USA INC drugs are available?

ORGANON USA INC has twenty-four approved drugs.

There are four US patents protecting ORGANON USA INC drugs. There is one tentative approval on ORGANON USA INC drugs.

There are ninety-five patent family members on ORGANON USA INC drugs in thirty-four countries and thirty-three supplementary protection certificates in ten countries.

Summary for Organon Usa Inc
International Patents:95
US Patents:4
Tradenames:27
Ingredients:22
NDAs:24
Patent Litigation for Organon Usa Inc: See patent lawsuits for Organon Usa Inc

Drugs and US Patents for Organon Usa Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc REVERSOL edrophonium chloride INJECTABLE;INJECTION 089624-001 May 13, 1988 DISCN No No ⤷  Try it Free ⤷  Try it Free
Organon Usa Inc HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 000552-010 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free
Organon Usa Inc HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 000552-008 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free
Organon Usa Inc LIQUAEMIN SODIUM heparin sodium INJECTABLE;INJECTION 000552-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Organon Usa Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc DESOGEN desogestrel; ethinyl estradiol TABLET;ORAL-21 020071-001 Dec 10, 1992 3,927,046 ⤷  Try it Free
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-002 Apr 30, 1984 3,553,212 ⤷  Try it Free
Organon Usa Inc GANIRELIX ACETATE ganirelix acetate INJECTABLE;INJECTION 021057-001 Jul 29, 1999 4,801,577 ⤷  Try it Free
Organon Usa Inc REMERON mirtazapine TABLET;ORAL 020415-001 Jun 14, 1996 5,977,099 ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ORGANON USA INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 250 mcg/0.5 mL, 1 mL PFS ➤ Subscribe 2012-03-30

Supplementary Protection Certificates for Organon Usa Inc Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0771217 07C0001 France ⤷  Try it Free PRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804
1453521 122015000093 Germany ⤷  Try it Free PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129
1453521 93156 Luxembourg ⤷  Try it Free PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211
2481400 C02481400/01 Switzerland ⤷  Try it Free PRODUCT NAME: CALCIFEDIOL; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67614 22.12.2020
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Baxter
Mallinckrodt
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.